The program, called Cancer Kitso, is being developed by the Botswana-Rutgers Partnership for Health to educate health care workers about cancer care and prevention. Pharmacists Joyce Kgatlwane and Jiyeon Joy Park discuss their involvement.
HIV/AIDS
Botswana Cancer Initiative Leader Discusses Parallels with AIDS and Progress on Oncology Workforce Training
Refeletswe Lebelonyane is a physician, public health professional, and program manager for the Botswana-Rutgers Partnership for Health. In this Q&A, she provides updates on cancer care and prevention efforts in Botswana and reflects on her past experiences confronting HIV/AIDS in the African country.
Officials Question Why FDA Continues to Restrict Gay Blood Donors
School of Public Health researcher Kristen Krause, an instructor in the Department of Urban-Global Public Health, discusses FDA restrictions on who can and cannot donate blood and the impact for men who have sex with men, a population that is subject to such restrictions.
Bloomberg Podcast Features Institute Director Discussing Omicron Response
In an episode of the Bloomberg Balance of Power podcast titled “Responding to the Omicron Variant,” Rutgers Global Health Institute director Richard Marlink talks about vaccination uptake, protecting older people, mask mandates, frustrations with government officials, travel bans, and holiday gatherings.
No Longer a Death Sentence: Transforming Cancer Care and Prevention in Africa
A Rutgers Global Health Institute initiative combines advancements in telemedicine with lessons learned from earlier battles against HIV to increase cancer survival rates in an area that needs it the most.
Project Map Spotlight: Mosaico, a Phase III Clinical Vaccine Trial to Prevent HIV Infection
While the overall rates of HIV/AIDS have decreased, the risk of infections within certain populations has surged. New Jersey Medical School faculty member Shobha Swaminathan is a clinical site leader for a vaccine trial that aims to provide HIV immunity for life.
Marlink Presents at AIDS 2020 Conference
The integration of cancer control into HIV settings in sub-Saharan Africa was the subject of Rutgers Global Health Institute director Richard Marlink’s presentation at the 23rd International AIDS Conference.
Impact of COVID-19 in Sub-Saharan Africa
COVID-19 has reached many sub-Saharan African countries that are already suffering from malnutrition and disease, under-resourced health systems, and limited economic funding. Richard Marlink, director of Rutgers Global Health Institute and a leader in the global response to HIV/AIDS, discusses how this pandemic is likely to impact the African region and what can be done to help these countries.
We’ve saved millions of people with HIV/AIDS. Now, let’s do the same for cancer.
In an op-ed for the Star-Ledger, Richard Marlink discusses the need to address cancer care and prevention disparities in sub-Saharan Africa, where aging HIV-positive populations face an increased risk of certain cancers.
Marlink to Mandela Fellows: Big Changes Needed to End AIDS Epidemic
During a seminar with the Rutgers cohort of 25 young African leaders, institute director Richard Marlink led a discussion about mobilizing three essential strategies to end the epidemic: follow the science, treat the whole person, and expand the health care workforce.